Literature DB >> 2685021

Identification of Clostridium difficile in stool specimens by culture-enhanced gas-liquid chromatography.

L L Johnson1, L V McFarland, P Dearing, V Raisys, F D Schoenknecht.   

Abstract

We have developed a sensitive and specific method for the identification of Clostridium difficile in stool specimens based on the detection of metabolic breakdown products of the organism by gas-liquid chromatography after incubation of stool samples in a selective broth medium containing cefoxitin. Use of this approach to test samples from two different populations of patients at separate medical centers showed this method to be superior to plate cultures or cytotoxin testing alone for both populations. The combined results from the two patient populations showed that 225 of 226 confirmed isolates were identified correctly, resulting in a sensitivity of 99.6% and a specificity of 99.0%. This method eliminates the delay caused by subculturing for tests requiring a pure isolate. The culture phase amplifies even low numbers of C. difficile in fecal samples (due to low in vivo concentrations or delayed transport) and thus increases sensitivity. Other advantages include the ability to detect C. difficile in the mixed flora of the stool and the ability of most clinical laboratories to use this procedure. Given the complexities of the detection of C. difficile toxins and the increasing importance of this organism as a nosocomial agent, culture-based methods remain the preferred approach to screening and routine workup for cases of diarrhea.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2685021      PMCID: PMC266997          DOI: 10.1128/jcm.27.10.2218-2221.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  Cytotoxicity assay in antibiotic-associated colitis.

Authors:  T W Chang; M Lauermann; J G Bartlett
Journal:  J Infect Dis       Date:  1979-11       Impact factor: 5.226

2.  Rectal swab cultures for Clostridium difficile surveillance studies.

Authors:  L V McFarland; M B Coyle; W H Kremer; W E Stamm
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

3.  Changing epidemiology, diagnosis, and treatment of Clostridium difficile toxin-associated colitis.

Authors:  R W Talbot; R C Walker; R W Beart
Journal:  Br J Surg       Date:  1986-06       Impact factor: 6.939

Review 4.  Review of frequency-pulsed electron-capture gas-liquid chromatography studies of diarrheal diseases caused by members of the family Enterobacteriaceae, Clostridium difficile, and rotavirus.

Authors:  J B Brooks
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

5.  Effect of antibiotic concentration in a selective medium on the isolation of Clostridium difficile from faecal specimens.

Authors:  P N Levett
Journal:  J Clin Pathol       Date:  1985-02       Impact factor: 3.411

6.  Clostridium difficile culture-positive toxin-negative diarrhea.

Authors:  B A Lashner; J Todorczuk; D F Sahm; S B Hanauer
Journal:  Am J Gastroenterol       Date:  1986-10       Impact factor: 10.864

Review 7.  Review of Clostridium difficile-associated diseases.

Authors:  L V McFarland; W E Stamm
Journal:  Am J Infect Control       Date:  1986-06       Impact factor: 2.918

8.  Comparison of Minitek Anaerobe II, API An-Ident, and RapID ANA systems for identification of Clostridium difficile.

Authors:  G Bate
Journal:  Am J Clin Pathol       Date:  1986-06       Impact factor: 2.493

9.  Selective and differential medium for isolation of Clostridium difficile.

Authors:  W L George; V L Sutter; D Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

10.  Effect of adding sodium taurocholate to selective media on the recovery of Clostridium difficile from environmental surfaces.

Authors:  B P Buggy; C C Hawkins; R Fekety
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

View more
  6 in total

1.  Comparison of a dot immunobinding assay, latex agglutination, and cytotoxin assay for laboratory diagnosis of Clostridium difficile-associated diarrhea.

Authors:  G L Woods; P C Iwen
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

2.  Correlation of immunoblot type, enterotoxin production, and cytotoxin production with clinical manifestations of Clostridium difficile infection in a cohort of hospitalized patients.

Authors:  L V McFarland; G W Elmer; W E Stamm; M E Mulligan
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

3.  A novel method for rapidly diagnosing the causes of diarrhoea.

Authors:  C S J Probert; P R H Jones; N M Ratcliffe
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

4.  Six rapid tests for direct detection of Clostridium difficile and its toxins in fecal samples compared with the fibroblast cytotoxicity assay.

Authors:  David K Turgeon; Thomas J Novicki; John Quick; LaDonna Carlson; Pat Miller; Bruce Ulness; Anne Cent; Rhoda Ashley; Ann Larson; Marie Coyle; Ajit P Limaye; Brad T Cookson; Thomas R Fritsche
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

Review 5.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

6.  Prevention of further recurrences of Clostridium difficile colitis with Saccharomyces boulardii.

Authors:  M B Kimmey; G W Elmer; C M Surawicz; L V McFarland
Journal:  Dig Dis Sci       Date:  1990-07       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.